Skip to content
Menu

Sutro Biopharma, Inc. STRO

Full chart Compare
Set alert

Price alert · STRO

All alert types
8.72 USD +0.22 (+2.59%)

Regular-session close

8.72 0.00 0.00%

After hours · Nov 19, 4:26 PM ET

8.48 Day range 8.98
7.15 52-week range 43.85
YTD
-24.63%
1 year
-4.18%

STRO free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-178,926,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-178,926,00015,712,000Not meaningful
FY 20242024-12-31-194,638,000-78,707,000Not meaningful
FY 20232023-12-31-115,931,000-111,622,000Not meaningful
FY 20222022-12-31-4,309,00092,693,000Not meaningful
FY 20212021-12-31-97,002,000-22,071,000Not meaningful
FY 20202020-12-31-74,931,000-6,427,000Not meaningful
FY 20192019-12-31-68,504,000-79,630,000-715.71%
FY 20182018-12-3111,126,00051,515,000Not meaningful
FY 20172017-12-31-40,389,000-22,858,000Not meaningful
FY 20162016-12-31-17,531,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:16.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.